Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 2/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.47 |
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | PPARG | P37231 | 9/20 | 0.43 |
| ▸ | PPARD | Q03181 | 5/20 | 0.43 |
| ▸ | PPARA | Q07869 | 4/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1541948 | 0.89 | ITGB3 (0.59) | ITGB3ITGA2BLTA4HPTPN1 | |
| SCHEMBL16940459 | 0.88 | ITGB3 (0.51) | ACACBITGB3ITGA2BLTA4H | |
| SCHEMBL106531 | 0.85 | LDHA (0.53) | ACACBLTA4HPPARGPPARAPTPN1 | |
| SCHEMBL7518497 | 0.85 | LDHA (0.53) | ACACBLTA4HPPARGPPARAPTPN1 | |
| SCHEMBL7346010 | 0.85 | LDHA (0.53) | ACACBLTA4HPPARGPPARAPTPN1 | |
| SCHEMBL6871466 | 0.85 | ITGB3 (0.51) | ITGB3ITGA2BLTA4HPPARG | |
| SCHEMBL16173552 | 0.84 | LTA4H (0.46) | ACACBITGB3ITGA2BLTA4HPTPN1 | |
| SCHEMBL14405380 | 0.84 | LTA4H (0.46) | ACACBITGB3ITGA2BLTA4HPTPN1 | |
| Acetic Acid SCHEMBL6866559 | 0.83 | ITGB3 (0.47) | ACACBITGB3ITGA2BLTA4HPPARG | |
| SCHEMBL27564491 | 0.83 | LTA4H (0.46) | ACACBITGB3ITGA2BLTA4HPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992014706-A1 | CYCLOPENTANE-DERIVED GLUTARAMIDE ANTIHYPERTENSIVE AGENTS | PFIZER LIMITED (GB) | 1992-09-03 | — | — | WO | disclosed |